# Dose-Exposure-Response in Type 1 Diabetes Mellitus

> **NCT00368394** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 18 (—)

## Conditions studied

- Diabetes Mellitus, Type I

## Interventions

- **DRUG:** Insulin glulisine

## Key facts

- **NCT ID:** NCT00368394
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 18 (—)
- **Last updated:** 2006-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00368394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00368394, "Dose-Exposure-Response in Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00368394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*